维普中文期刊产品整合服务
103篇 您的检索式:作者名="PIGNATA S"
    题名 作者 年代 出处 被引量
1Ovarian cancer in the elderly显示文摘 Vermorken JB 2004Crit Rev Oncol Hematol2004,49,:1
2Phase Ⅱ study of cisplatin and vinorelbmine as first-line chemotherapy in patients with carainoma of the uterine cervix显示文摘Pignata S Silveslro G Ferrari E 1999J Clin Oncol1999,17,3:1
3Evaluation ofpemetrexed (alimta,ly231514) as second-linechemotherapy in persistent or recurrent carcinoma of thecervix: the cervix 1 study of the mito (multicentre italiantrials in ovarian cancer and gynecologic malignancies)group 显示文摘Lorusso D Ferrandina G Pignata S 2010Ann Oncol2010,21,1:1
4Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer:aphase Ⅱstudy显示文摘Vagno G Connio G Pignata S 2003Int J Gynecol Cancer2003,13,3:1
5Residual neurotoxicity in ovariancancer patients in clinical remission after first-line chemotherapy with carboplatin andpaclitaxel: the Multicenter Italian Trial in Ovarian Cancer (MITO-4) retrospective study 显示文摘Pignata S De Placido S Biamonte R 2006BMC Cancer2006,6,:1
6Carboplatin and pegylated liposomald-oxorubicin for advanced ovarian cancer:preliminary activity results of the MITO-2 phaseⅢtrial显示文摘Pignata S ScambiaG SavareseA 0,,:1
7Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth faetor receptor reverse transcriptiou-PCR assay显示文摘De Luca A Pignata S Casamassimi A 2000Clin Cancer Res2000,6,4:1
8Evaluation of pemetrexed (Alimta, LY231514) as second-line chemo- therapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group显示文摘Lorusso D Ferrandina G Pignata S 2010Ann Oncol2010,21,1:1
9Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri显示文摘Pignata S Frezza P Tramontana S 2000Ann Oncol2000,11,4:1
10Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer:a phase study显示文摘Vagno G Cormio G Pignata S 2003Int J Gynecol Cancer2003,13,3:1
11Transforming growth factor al- pha,amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas显示文摘D'Antonio A Losito S Pignata S 2002Int J Oncol2002,21,5:1
12High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer显示文摘Califano D Pignata S Losito NS 2014J Cell Physiol2014,229,1:1
13Transforming growth fac- tor, amphiregnlin and cfipto-l are frequently expressed in advanced human ovarian carcinomas 显示文摘D' Antonio A Losito S Pignata S 2002In t J Oncol2002,21,5:1
14Angiogenesis:a promising therapeutic target for ovarian cancer显示文摘Bamias A Pignata S Pujade-Lauraine E 2012Crit Rev Oncol Hematol2012,84,3:1
15Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase Ⅱ study显示文摘Di Vagno G Cormio G Pignata S 2003Int J Gynecol Cancer2003,13,3:1
16Pegylated liposomal doxorubicin combined with carboplatin:a rational treatment choice for advanced ovarian cancer显示文摘Pignata S Lauraine EP du Bois A 2010Crit Rev Oncol Hematol2010,73,1:1
17Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription -PCR assay显示文摘De Luca A Pignata S Casamassimi A etal 2000Clin Cancer Res2000,6,:1
18Carboplatin and pegy- lated liposomal doxorubicin for advanced ovarian cancer: prelimi- nary activity results of the MITO-2 phase m tnl显示文摘Pignata S Scambia G Savarese A 2009Oneology2009,76,1:1
19The role of chemotherapy in the management of gastic cancer 显示文摘De V R Pignata S Palaia R 2000J Clin Gastroenterol2000,30,:1
20Effect of aspirin on cell proliferation and differentiation of colon adenocarcinom Caco-2 cella 显示文摘Richi P Pignata S Di Popolo A 1997Iht J cANCER1997,73,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费